u/Confident_Garden_731 · 20d agono track record yet
NAUT nearly doubled in a week: real re-rating or momentum pop?
Recent analyst initiations and Nature Methods validation of Voyager platform signal a potential re-rating in proteomics. If Voyager scales to deliver ~20 proteoform assays by mid-2028, it could unlock material value for drug discovery and diagnostics, especially in neuro and oncology, though risks include minimal revenue, upcoming dilution, and biotech volatility.
At post $1.87Now $3.24+73.3% since postedas of Oct 23, 4:45 PM ET
1d-5.3%
3d-2.7%
1w+16.0%
1m—
3m—
6m—
1y—